The latest statistics from South Africa reveal that intensive care admissions for the Omicron Covid variant are running at just a third of what they were at the same point in the country’s Delta wave. The figures come following the chair of the South African Medical Association (SAMA) reporting that Omicron’s symptoms are mostly “very, very mild” and could treated at home. With even US National Institute of Allergy and Infectious Diseases director Anthony Fauci now admitting the new variant is “almost certainly” not more severe than Delta, the question that urgently needs to be asked is a very simple one: why is global tension being raised to a state of panic?
A researcher involved in the clinical trial that was carried out to obtain ‘emergency use authorization’ for Pfizer’s COVID-19 vaccine has revealed that some of the study data claimed to have been obtained from the tests were falsified. In an alarming investigation that has been largely ignored by most of the pharma-compliant mainstream media, the British Medical Journal (BMJ) reports that staff conducting quality control checks for the trial were ‘overwhelmed’ by the volume of problems they were finding. With the full data used to license Pfizer’s vaccine still not having been publicly released, the revelations seriously undermine the claim that the mRNA technology utilized in the injection has been scientifically ‘proven’ to be safe.
Belatedly recognizing what the Dr. Rath Health Foundation has long been saying, the World Health Organization (WHO) recently admitted that vaccines alone will not be enough to end the COVID-19 pandemic. Speaking to Times Radio in the UK, WHO spokesperson Dr. Margaret Harris openly acknowledged that “we really have to do other measures” and that “the vaccine isn’t going to get us out of this.” Realistically however, the other measures Harris proposes – avoiding crowds and wearing masks – are not practical long-term solutions. With the WHO clearly bereft of new ideas and still answering primarily to its pharmaceutical industry stakeholders, the need for the implementation of science-based alternatives to COVID-19 vaccines has never been more urgent.